ALT as a non-invasive biomarker of histological response to pharmacotherapy in NASH patients: insights from the elafibranor GOLDEN505 trial

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Ratziu V, Harrison SA, Francque S, Bedossa P, Anstee QM, Ben Sudrik F, Roudot A, Megnien S, Hum DW, Hanf R, Staels B, Sanyal AJ

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016

Year of Conference: 2016

Pages: 581A-582A

Print publication date: 01/10/2016

Acceptance date: 02/04/2016

ISSN: 0270-9139

Publisher: Wiley-Blackwell

URL: http://doi.org/10.1002/hep.28798

DOI: 10.1002/hep.28798

Series Title: Hepatology

ePrints